The Panomles Approach in Neurodegenerative Disorders

被引:3
|
作者
Szatmari, Balazs [1 ]
Balicza, Peter [2 ]
Nemeth, Gyorgy [1 ]
Molnar, Maria Judit [2 ]
机构
[1] Gedeon Richter Plc, Med Div, Budapest, Hungary
[2] Semmelweis Univ, Inst Genom Med & Rare Dis Orders, Budapest, Hungary
关键词
Omics; classification; neurodegenerative disorders; multidisciplinary approach; genetics; imaging; AMYOTROPHIC-LATERAL-SCLEROSIS; FRONTOTEMPORAL LOBAR DEGENERATION; ALZHEIMERS-DISEASE; MICROGLIAL ACTIVATION; PARKINSONS-DISEASE; TREM2; VARIANTS; PET; PATHOLOGY; NEUROINFLAMMATION; SAFETY;
D O I
10.2174/0929867324666170705120038
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Background: The molecular genetic technologies revolutionized the diagnostics of many disorders. Thanks to the new molecular techniques and the rapid improvement of the information technologies the number of mendelien inherited disorders has increased rapidly in the last five years. The omics era brought radical changes in the understanding of complex disorders and the underlying pathomechanisms. However, in most complex disorders the genome wide association studies could not clarify the genetic background even for disorders where a very strong heritability had been observed. Objective: In this paper the changing concept of the neurodegenerative disorders is discussed. The traditional classification of these disorders was purely based on clinical symptoms and morphological signs in the last century. Identifying the signature lesions of various neurodegenerative disorders may reveal a common pathological pathway in these disorders, New neuroimaging methods provided additional tools to assess pathological pathways in vivo already in the early stages of the diseases, Visualizing in vivo amyloid deposits and neuroinflammation improved our understanding of their role in various neurodegenerative disorders. Genetics may be the most precise way to identify the background of these disorders, However, there is only limited number of cases where true association can he proved between the disorder and the genetic mutations. Most of the neurodegenerative disorders seem to be multifactorial and cannot be traced back to one single cause. Conclusion: In conclusion, shifting from a classification based on symptomatology only to a modern multidisciplinary approach, based on the constantly evolving panomics findings, would improve our understanding of neurodegenerative diseases and could be the basis of novel therapeutic research.
引用
收藏
页码:1712 / 1720
页数:9
相关论文
共 50 条
  • [1] Imaging Neuroinflammation in Neurodegenerative Disorders
    Masdeu, Joseph C.
    Pascual, Belen
    Fujita, Masahiro
    JOURNAL OF NUCLEAR MEDICINE, 2022, 63 : 45S - 52S
  • [2] Neuroinflammation as a Common Feature of Neurodegenerative Disorders
    Guzman-Martinez, Leonardo
    Maccioni, Ricardo B.
    Andrade, Victor
    Patricio Navarrete, Leonardo
    Gabriela Pastor, Maria
    Ramos-Escobar, Nicolas
    FRONTIERS IN PHARMACOLOGY, 2019, 10
  • [3] Synaptic Effects of Palmitoylethanolamide in Neurodegenerative Disorders
    Assogna, Martina
    Di Lorenzo, Francesco
    Martorana, Alessandro
    Koch, Giacomo
    BIOMOLECULES, 2022, 12 (08)
  • [4] Targeting TRPs in Neurodegenerative Disorders
    Takada, Yoshinori
    Numata, Tomohiro
    Mori, Yasuo
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2013, 13 (03) : 322 - 334
  • [5] Modeling neurodegenerative disorders in zebrafish
    Bashirzade, Alim A.
    Zabegalov, Konstantin N.
    Volgin, Andrey D.
    Belova, Alisa S.
    Demin, Konstantin A.
    de Abreu, Murilo S.
    Babchenko, Vladislav Ya.
    Bashirzade, Kseniya A.
    Yenkoyan, Konstantin B.
    Tikhonova, Maria A.
    Amstislavskaya, Tamara G.
    V. Kalueff, Allan
    NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 2022, 138
  • [6] Reactive Aldehydes and Neurodegenerative Disorders
    Matveychuk, Dmitriy
    Dursun, Serdar M.
    Wood, Paul L.
    Baker, Glen B.
    KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY, 2011, 21 (04): : 277 - 288
  • [7] ADSC Therapy in Neurodegenerative Disorders
    Chan, Tzu-Min
    Chen, Julia Yi-Ru
    Ho, Li-Ing
    Lin, Hui-Ping
    Hsueh, Kuo-Wei
    Liu, Demeral David
    Chen, Yi-Hung
    Hsieh, An-Cheng
    Tsai, Nu-Man
    Hueng, Dueng-Yuan
    Tsai, Sheng-Tzeng
    Chou, Pei-Wen
    Lin, Shinn-Zong
    Harn, Horng-Jyh
    CELL TRANSPLANTATION, 2014, 23 (4-5) : 549 - 557
  • [8] Inflammation in Metal-Induced Neurological Disorders and Neurodegenerative Diseases
    Wei, Ruokun
    Wei, Peiqi
    Yuan, Haiyan
    Yi, Xiang
    Aschner, Michael
    Jiang, Yue-ming
    Li, Shao-jun
    BIOLOGICAL TRACE ELEMENT RESEARCH, 2024, 202 (10) : 4459 - 4481
  • [9] Role of melatonin supplementation in neurodegenerative disorders
    Polimeni, Giovanni
    Esposito, Emanuela
    Bevelacqua, Valentina
    Guarneri, Claudio
    Cuzzocrea, Salvatore
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2014, 19 : 429 - 446
  • [10] Role of Autophagy and Mitophagy in Neurodegenerative Disorders
    Kapil, Lakshay
    Kumar, Vishal
    Kaur, Simranjit
    Sharma, Deepali
    Singh, Charan
    Singh, Arti
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2024, 23 (03) : 367 - 383